By Jason Derry —

Elusys Therapeutics, Inc. has
announced an exclusive license with Pfizer Inc. to collaborate in the development of new therapeutics for infectious
diseases.  The agreement relates to the
use of Elusys' HP Antibody® technology.

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.